• HOME
  • ABOUT US
  • NEWS
  • OUTPUT
  • Technology Platforms
    • Cell analysis
    • Genomics
    • Extended RNA analysis platform
    • Imaging technologies
    • New radiation techniques
    • Virus production technologies
    • Tumorbank
    • Proteomics
  • our teams
  • CONTACT
Skip to content
  • Jobs
  • Partners
  • English
  • Nederlands
  • Français
Logo
  • HOME
  • ABOUT US
  • NEWS
  • OUTPUT
  • Technology Platforms
    • Cell analysis
    • Genomics
    • Extended RNA analysis platform
    • Imaging technologies
    • New radiation techniques
    • Virus production technologies
    • Tumorbank
    • Proteomics
  • our teams
  • CONTACT

Author: Els Van Valckenborgh

27Sep

Can epigenetic treatment restore the immune system in multiple myeloma?

by Els Van Valckenborgh in Research Oncologie
Researchers of the laboratory Hematology and Immunology investigated the immunomodulatory properties of epigenetic modulating agents in multiple myeloma. Multiple myeloma is an incurable cancer of plasma cells that grow in...
Read More
21Sep

EMBO Workshop 24-27 October 2018 – Ghent

by Els Van Valckenborgh in Research Oncologie
For more information: http://meetings.embo.org/event/18-phagocytosis
Read More
26Jul

VUB scientist Sylvia Faict receives New Investigator Award for her research

by Els Van Valckenborgh in Research Oncologie
VUB researcher Sylvia Faict of the research group Hematology and Immunology group (HEIM) has received the New Investigator Award from the Cancer and Bone Society, as part of her research...
Read More
20Jun

7-9 MARCH 2019: 3rd international conference on end of life law, ethics, policy, and practice

by Els Van Valckenborgh in Research Oncologie
More information on the Conference website: https://icel3.org/    
Read More
01Jun

25-26 OCT 2018: Public health research in palliative care: shifting the paradigm

by Els Van Valckenborgh in Research Oncologie
International Seminar of EAPC RN and the EAPC Reference Group on Public Health and Palliative Care More information here
Read More
23Mar

Hilde Bruers Award for VUB researcher Dr. Damya Laoui

by Els Van Valckenborgh in Research Oncologie
VUB researcher Dr. Damya Laoui from the lab Myeloid Cell Immunology received the Hilde Bruers Award for her research on the use of dendritic cells as immunotherapy in cancer. The...
Read More
01Mar

Rising Star Award for Professor Ilse Rooman

by Els Van Valckenborgh in Research Oncologie
Every year the National Societies Committee and the United European Gastroenterology (UEG) Scientific Committee jointly select 6-8 emerging clinical scientists as Rising Stars. This year Prof. Ilse Rooman from the...
Read More
01Mar

Palliatieve zorg vroeg opstarten verbetert de levenskwaliteit

by Els Van Valckenborgh in Research Oncologie
Dutch text only Onderzoekers van de onderzoeksgroep Zorg rond het Levenseinde (VUB-UGent) stelden samen met het UZ Gent vast dat vroege palliatieve zorg voor mensen met ongeneeslijke kanker meer levenskwaliteit...
Read More
01Mar

Prof. Eline Menu presents at the Annual Meeting of the Belgian Hematology Society

by Els Van Valckenborgh in Research Oncologie
Professor Eline Menu from the research group Hematology and Immunology group presented at the Annual Meeting of the Belgian Hematology Society their latest results on exosomes in Multiple Myeloma. The...
Read More

Recent Posts

  • Lab visit: students from 5th year secondary school (finality sciences) – OLV in Sint-Genesius-Rode
  • Karin Vanderkerken selected as member of Royal Flemish Academy of Belgium for Science and the Arts
  • 13th KUBEC Forum and ORC Day 2023
  • The progress of cancer research
  • The VUB Foundation: how do funds support cancer research at VUB?

Contact

Dr. Isabelle Houbracken
orc@vub.be

Our Mission

To advance scientific knowledge in the field of oncology for the benefit of the patients.


Copyright © 2022 ORC | Wordpress website by Studio Mikado